Mar 3, 2026 04:08PM
Feb 2, 2026 06:21AM
Jan 27, 2026 07:07AM
Jan 14, 2026 10:00AM
Jan 13, 2026 07:32AM
Dec 9, 2025 07:58AM
Dec 8, 2025 08:01AM NeuroPace reports 77% seizure reduction in epilepsy trial at 18 months
Nov 24, 2025 08:00AM
Nov 10, 2025 09:21AM
Nov 5, 2025 06:20AM
Nov 5, 2025 06:04AM
Nov 4, 2025 04:36PM
Sep 9, 2025 08:58AM
Aug 14, 2025 06:04AM NeuroPace Inc (NPCE) PT Lowered to $13 at Wolfe Research
Aug 13, 2025 05:22AM
Aug 12, 2025 04:11PM
Aug 1, 2025 07:30AM
Jun 26, 2025 08:01AM
Jun 25, 2025 07:06AM
Jun 24, 2025 04:05PM
Jun 16, 2025 07:00AM Cantor Fitzgerald Reiterates Overweight Rating on NeuroPace Inc (NPCE)
Jun 12, 2025 10:25AM
Jun 12, 2025 07:20AM
Jun 4, 2025 04:10PM
Jun 2, 2025 06:53AM
May 28, 2025 06:45AM
May 27, 2025 01:05PM
May 27, 2025 11:26AM Leerink Partners Reiterates Outperform Rating on NeuroPace Inc (NPCE)
May 27, 2025 08:03AM
May 19, 2025 06:46AM
May 13, 2025 04:13PM
Apr 14, 2025 04:07PM
Apr 14, 2025 07:03AM
Apr 10, 2025 06:48AM
Apr 8, 2025 08:02AM NeuroPace (NPCE) Announces Data From a Long-Term Post-Approval Study of the RNS System in Focal Epilepsy at the 2025 AAN Annual Meeting
Apr 2, 2025 04:07PM
Mar 18, 2025 06:36AM
Mar 17, 2025 07:38AM
Mar 10, 2025 07:08AM
Mar 5, 2025 07:07AM
Mar 4, 2025 04:09PM
Feb 14, 2025 06:36AM NeuroPace (NPCE) Announces Pricing of Public Offering of $65M of Common Stock
Feb 13, 2025 04:34PM
Jan 21, 2025 12:59AM
Dec 17, 2024 05:35AM
Nov 12, 2024 04:24PM
Nov 4, 2024 04:06PM
Oct 16, 2024 04:07PM
Sep 4, 2024 04:06PM NeuroPace (NPCE) Announces Two Management Appointments
Aug 14, 2024 05:28AM

353,174 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All